One Class of Antidiabetic Linked With Lower Kidney Stone Risk
(MedPage Today) -- One class of glucose-lowering agent may help lower the risk of kidney stones in adults with type 2 diabetes, a cohort study suggested.
Adults who newly started on an SGLT2 inhibitor had a 31% lower risk of nephrolithiasis compared...
Source: MedPage Today Cardiovascular - Category: Cardiology Source Type: news
More News: Cardiology | Cardiovascular | Diabetes | Diabetes Type 2 | Endocrinology | Heart | Kidney Stones | SGLT2 Inhibitors | Study | Urology & Nephrology